Medivolve Inc MEDVF

RE:RE:RE:Medivolve INC MEDV Possibly Ready for a Big Move

[Sarb99]

I did not cut and paste the good or bad information. I just shared the link that included the Disclaimer. So, people can read full information the way you did. Most of the investors are smarter than you and me. They can decide themself what to buy or sell and at what price. 

 

I am just an investor like everyone else here. I don't issue any recommendations to buy or sell.  

 

Read my post again and tell me what extra did I say or recommended to or sell:  https://smallcapexclusive.com/medivolve-inc-otc-coprf-neo-medv-is-possibly-ready-for-a-big-move/

Look at trading data from today, many people sold manipulating. 

House Positions for C:MEDV from 20210305 to 20210305

House	Bought	$Val	Ave	Sold	$Val	Ave	Net	$Net
33 Canaccord	1,443,834	427,526	0.296	374,218	108,583	0.29	1,069,616	-318,943
7 TD Sec	1,106,594	322,357	0.291	366,130	110,140	0.301	740,464	-212,217
14 ITG	84,000	23,910	0.285	4,000	1,200	0.30	80,000	-22,710
124 Questrade	69,410	20,800	0.30	11,500	3,750	0.326	57,910	-17,050
80 National Bank	143,728	42,356	0.295	90,374	26,513	0.293	53,354	-15,843
39 Merrill Lynch	24,000	7,820	0.326	6,000	1,760	0.293	18,000	-6,060
9 BMO Nesbitt	6,000	1,710	0.285	19,000	5,270	0.277	-13,000	3,560
212 Virtu	81,124	22,636	0.279	98,423	29,857	0.303	-17,299	7,221
19 Desjardins	32,000	10,220	0.319	92,000	28,232	0.307	-60,000	18,012
79 CIBC	77,876	22,159	0.285	154,150	47,370	0.307	-76,274	25,211
13 Instinet	0			108,000	31,524	0.292	-108,000	31,524
85 Scotia	16,400	4,751	0.29	278,400	86,181	0.31	-262,000	81,430
1 Anonymous	1,373,314	403,513	0.294	1,884,000	556,187	0.295	-510,686	152,674
2 RBC	434,481	126,388	0.291	1,406,566	399,580	0.284	-972,085	273,192
TOTAL	4,892,761	1,436,146	0.294	4,892,761	1,436,147	0.294	0	1

Hiddensecrets wrote: Talk about being a hyprocrite and disingenious towards other investors, you want them to buy MEDV based on paid advertising from MEDV?   

It is not a real article from an independent author.  

Disclaimer

Small Cap Exclusive is owned and operated by JBN PARTNERS LLC, which is a US based corporation. We are paid advertisers, also known as stock touts or stock promoters, who disseminate favorable information (this “Article”) about publicly traded companies (the “Profiled Issuers”).

We publish the Information on our website, smallcapexclusive.com and in newsletters, text message alerts, audio services, live interviews, featured “research” reports, on message boards and in email communications for specific time periods that are agreed upon between us and the Profiled Issuer and / or third party paying us. Our publication of the Information is known as a “Campaign”. This information may be sent to potential investors at different times that are minutes, hours, days or even weeks apart. Typically, the trading volume and price of a Profiled Issuer’s securities increases after the information is provided to the first group of investors. Therefore, the later an investor receives the Information, the more likely it is that he will suffer trading losses if they purchase the securities of a Profiled Issuer late in a Campaign. We are paid to advertise the Profiled Issuers, Medivolve, Inc. Small Cap Exclusive has been hired by Medivolve, Inc. for a period beginning on March 3, 2021 to publicly disseminate information about (COPRF) via website and email. We have been compensated $50,000 USD. We will update any changes to our compensation.